Results 11 to 20 of about 491,575 (216)

Hyperthermic Intraperitoneal Chemotherapy: A Critical Review [PDF]

Cancers, 2021
With increasing awareness amongst physicians and improved radiological imaging techniques, the peritoneal cavity is increasingly recognized as an important metastatic site in various malignancies. Prognosis of these patients is usually poor as traditional treatment including surgical resection or systemic treatment is relatively ineffective ...
Wim Ceelen, Jesse Demuytere, Ignace de Hingh   +2 more
openaire   +5 more sources

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2021
Objective To investigate the therapeutic efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) as consolidation treatment after completing first-line treatment in patients with advanced ovarian cancer.
Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Joon Mo Lee   +8 more
doaj   +1 more source

Current Situation of Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinoma

Zhongliu Fangzhi Yanjiu, 2021
Peritoneal carcinoma is a kind of malignant tumor which occurs and develops on the peritoneum, including primary and secondary tumors. Hyperthermic intraperitoneal chemotherapy is a combined therapy of intraperitoneal perfusion, hyperthermia and ...
ZHAN Hongjie, LIANG Han
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting

International Journal of Hyperthermia, 2021
Purpose We aimed to determine the effects and possible mechanisms of hyperthermic intraperitoneal chemotherapy (HIPEC) in targeting ovarian cancer stem-like cells (CSCs).
Chao-Chih Wu, Yun-Ting Hsu, Chih-Long Chang   +2 more
doaj   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]

New England Journal of Medicine, 2018
(Abstracted from N Engl J Med 2018;378:230–240) The majority of patients with ovarian cancer (OC) receive an initial diagnosis of advanced disease that has spread from the ovaries to the peritoneal surface. The most effective treatment for patients with advanced disease is cytoreductive surgery followed by systemic chemotherapy.
Willemien J. van Driel, Simone N. Koole, Karolina Sikorska, Jules H. Schagen van Leeuwen, Henk W.R. Schreuder, Ralph H.M. Hermans, Ignace H.J.T. de Hingh, Jacobus van der Velden, Henriëtte J. Arts, Leon F.A.G. Massuger, Arend G.J. Aalbers, Victor J. Verwaal, Jacobien M. Kieffer, Koen K. Van de Vijver, Harm van Tinteren, Neil K. Aaronson, Gabe S. Sonke   +16 more
openaire   +18 more sources

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019
Objective: The aim of this study is to present our initial implementation experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the light of current ...
Talgat Uskenbayev, Altay Kerimkulov, Adilbek Mukazhanov, Meiram Mamlin, Rimbay Kaliyev   +4 more
doaj   +1 more source

Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects

Креативная хирургия и онкология, 2021
Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev, K. Sh. Gantsev, Sh. R. Kzyrgalin, K. R. Ishmuratova   +3 more
doaj   +1 more source

Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Gynecologic Oncology Reports, 2020
Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery ...
Nicholas K. Larsen, Matthew J. Reilly, Seunghyug Kwon, Brian W. Loggie, Marcus W. Balters   +4 more
doaj   +1 more source

Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae

Pleura and Peritoneum, 2022
Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais, Liauw Winston, Kennedy Helen, Alzahrani Nayef A., Morris David L.   +4 more
doaj   +1 more source

Initial Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]

Archives of Surgery, 2012
Until 2004, we treated peritoneal carcinomatosis with cytoreductive surgery accompanied by perioperative systemic chemotherapy. From October 2004, we decided to initiate a hyperthermic intraperitoneal chemotherapy (HIPEC) program for this condition.To determine the effect of HIPEC on postoperative outcomes at a single institution performing a high ...
Olivier, Turrini, Eric, Lambaudie, Marion, Faucher, Frédéric, Viret, Jean Louis, Blache, Gilles, Houvenaeghel, Jean Robert, Delpero   +6 more
openaire   +2 more sources